TipRanks
pc:biosc

32 Biosciences

https://www.32biosciences.com/
A gastrointestinal-focused biotechnology company developing therapies and discovery tools to restore and protect the gut mucosal-immune system. The company is advancing CS-0003, a first-in-class Mucosal-Immune Modulator, and GB, a metabolomics-based GI discovery platform, with an initial focus on preventing GI surgical site infections and potential expansion into IBD and prevention of colon cancer recurrence.

Leadership & Board

Current Number of Employees10
Current LinkedIn Followers1,007

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$40M
Total Amount Raised$40M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$40M
Latest Funding Amount$40M
Latest Funding RoundSeries A
Latest Funding RoundSeries A
Post-Money Valuation
Post-Money Valuation

Employee Trend

32 Biosciences had 10 employees as of September 14, 2026. The number of employees increased by 0 (0.00%) week-over-week.
10Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.

Social Trend

32 Biosciences had 1,007 followers as of September 14, 2026. The number of followers increased by 3 (0.30%) week-over-week.
1,007Latest Followers Count
3(0.30%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jan 08, 2026
Series A
$40.00M

Similar Companies

A snapshot of private companies similar to 32 Biosciences, helping you discover and navigate related company profiles.

Related News and Analysis